Identification of independent risk factors for the development of diabetic retinopathy requiring treatment

Acta Ophthalmologica

Volumn 89, Issue 6, 2011, Pages 515-521

  Mehlsen, Jesper ^a   Erlandsen, Mogens ^b   Poulsen, Per L ^a   Bek, Toke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

diabetic retinopathy; risk factors; screening interval

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISABILITY SEVERITY; DISEASE COURSE; DISEASE DURATION; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SLIT LAMP; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; OPHTHALMOSCOPY; RISK FACTORS; TIME FACTORS;

EID: 80052083852     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01742.x     Document Type: Article

References (49)

1. Adler AI, Stratton IM, Neil HA, et al., (2000): Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412-419. (Pubitemid 30609443)
2. Agardh CD, Agardh E, &, Torffvit O, (1997): The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract 35: 113-121. (Pubitemid 27224236)
3. ® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. Available at:. [Accessed October 2009].
4. Bek T, &, Erlandsen M, (2006): Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol Scand 84: 16-20. (Pubitemid 43337468)
5. Bek T, &, Helgesen A, (2001): The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. Acta Ophthalmol Scand 79: 501-505. (Pubitemid 32962843)
6. Bek T, &, Kjaergaard J, (2004): The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes. Eur J Ophthalmol 14: 538-542. (Pubitemid 40127968)
7. Bek T, Moller F, &, Klausen B, (2000): Short term visual prognosis after retinal laser photocoagulation for diabetic maculopathy. Acta Ophthalmol Scand 78: 539-542.
8. Canada Institute of Health Economics (2008): Alberta Diabetes Atlas, Canada Institute of Health Economics. Available at:. [Accessed January 2009.]
9. Carstensen B, Kristensen JK, Ottosen P, &, Borch-Johnsen K, (2008): The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51: 2187-2196.
10. Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G, &, Crews MJ, (1990): Blood pressure and retinopathy in type I diabetes. Ophthalmology 97: 155-159. (Pubitemid 20051376)
11. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, &, Fuller JH, (1998): Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-dependent Diabetes Mellitus. Lancet 351: 28-31.
12. DCCT (1995): Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 102: 647-661.
13. Diggle PJ, Heagerty P, Liang KY, &, Zeger S, (2002): Analysis of longitudinal data. New York: American Statistical Association.
14. Dobree JH, (1970): Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. Br J Ophthalmol 54: 1-10.
15. Diabetic Retinopathy Study (DRS) Group (1978): Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 85: 82-106.
16. Diabetic Retinopathy Study (DRS) Group (1981): Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5. Dev Ophthalmol 2: 248-261.
17. Estacio RO, Jeffers BW, Gifford N, &, Schrier RW, (2000): Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 23 (Suppl 2): B54-B64. (Pubitemid 30185779)
18. Ferris FL III, Kassoff A, Bresnick GH, &, Bailey I, (1982): New visual acuity charts for clinical research. Am J Ophthalmol 94: 91-96. (Pubitemid 12080556)
19. Ferris FL III, Podgor MJ, &, Davis MD, (1987): Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12. Ophthalmology 94: 754-760. (Pubitemid 17123153)
20. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, &, Pedersen O, (2003): Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393. (Pubitemid 36159355)
21. Gallego PH, Craig ME, Hing S, &, Donaghue KC, (2008): Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ 2008; 337: a918.
22. Harris MI, &, Eastman RC, (2000): Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 16: 230-236. (Pubitemid 30611783)
23. Hove MN, Kristensen JK, Lauritzen T, &, Bek T, (2004): The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand 82: 443-448. (Pubitemid 39199446)
24. Hove MN, Kristensen JK, Lauritzen T, &, Bek T, (2006): The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 84: 619-623. (Pubitemid 44317540)
25. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, &, Pisinger C, (2003): A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-386. (Pubitemid 38037253)
26. Kaufman SC, Ferris FL III, Seigel DG, Davis MD, &, DeMets DL, (1989): Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13. Invest Ophthalmol Vis Sci 30: 23-28. (Pubitemid 19039875)
27. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984a): The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526. (Pubitemid 14127838)
28. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984b): The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532. (Pubitemid 14127839)
29. Klein R, Moss SE, Klein BE, Davis MD, &, DeMets DL, (1988): The Wisconsin Epidemiologic Study of Diabetic Retinopathy: VIII. The incidence of retinal photocoagulation. J Diabet Complications 2: 79-87.
30. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, &, Mogensen CE, (2003): Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study. J Intern Med 254: 147-158. (Pubitemid 36900438)
31. Kuo HS, Chang HJ, Chou P, Teng L, &, Chen TH, (1999): A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM). Int J Epidemiol 28: 233-240. (Pubitemid 29176649)
32. Larsen M, Hommel E, Parving HH, &, Lund-Andersen H, (1990): Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol 228: 505-509. (Pubitemid 20362507)
33. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, &, Rutten G, (2000): The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24 (Suppl 3): 6-11.
34. Marshall G, Garg SK, Jackson WE, Holmes DL, &, Chase HP, (1993): Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100: 1133-1139. (Pubitemid 23226807)
35. Matthews DR, Stratton IM, Aldington SJ, Holman RR, &, Kohner EM, (2004): Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 122: 1631-1640. (Pubitemid 39473407)
36. Mehler PS, Jeffers BW, Estacio R, &, Schrier RW, (1997): Associations of hypertension and complications in non-insulin-dependent diabetes mellitus. Am J Hypertens 10: 152-161. (Pubitemid 27084625)
37. Munier A, Gunning T, Kenny D, &, O'Keefe M, (1998): Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 82: 630-633. (Pubitemid 28306651)
38. Norton EW, &, Gutman F, (1965): Diabetic retinopathy studied by fluorescein angiography. Trans Am Ophthalmol Soc 63: 108-128.
39. Patel A, MacMahon S, Chalmers J, et al., (2007): Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370: 829-840. (Pubitemid 47362321)
40. Robins JM, Hernan MA, &, Brumback B, (2000): Marginal structural models and causal inference in epidemiology. Epidemiology 11: 550-560. (Pubitemid 30660034)
41. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, &, Agardh E, (2000): Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 78: 374-385. (Pubitemid 30609364)
42. Stratton IM, Adler AI, Neil HA, et al., (2000): Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412. (Pubitemid 30609442)
43. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, &, Matthews DR, (2001): UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44: 156-163. (Pubitemid 32156199)
44. Thompson TJ, Engelgau MM, Hegazy M, Ali MA, Sous ES, Badran A, &, Herman WH, (1996): The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabet Med 13: 337-340. (Pubitemid 26141699)
45. Turnbull B (1976): The empirical distribution function with arbitrarily grouped, censored and truncated data. J R S Soc Series B 38: 290-295.
46. UK Prospective Diabetes Study (UKPDS) Group (1998): Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 854-865.
47. WHO (2008): Diabetes fact sheet no. 312. Available at:. [Accessed January 2009.]
48. Younis N, Broadbent DM, Harding SP, &, Vora JP, (2003a): Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 20: 758-765. (Pubitemid 41701472)
49. Younis N, Broadbent DM, Vora JP, &, Harding SP, (2003b): Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361: 195-200. (Pubitemid 36126218)